Search details
1.
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination.
Clin Infect Dis
; 74(7): 1275-1278, 2022 04 09.
Article
in English
| MEDLINE | ID: mdl-34363462
2.
Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation.
Stat Med
; 41(24): 4745-4755, 2022 10 30.
Article
in English
| MEDLINE | ID: mdl-35818331
3.
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(1): 60-72, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31806543
4.
Estimation for an accelerated failure time model with intermediate states as auxiliary information.
Lifetime Data Anal
; 26(1): 1-20, 2020 01.
Article
in English
| MEDLINE | ID: mdl-30386969
5.
Are rare cancer survivors at elevated risk of subsequent new cancers?
BMC Cancer
; 19(1): 166, 2019 Feb 21.
Article
in English
| MEDLINE | ID: mdl-30791872
6.
Graphing the Win Ratio and its components over time.
Stat Med
; 38(1): 53-61, 2019 01 15.
Article
in English
| MEDLINE | ID: mdl-30206956
7.
Design and analysis of a clinical trial using previous trials as historical control.
Clin Trials
; 16(5): 531-538, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31256630
8.
Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project.
Am J Gastroenterol
; 111(2): 285-93, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26856748
9.
Global rank tests for multiple, possibly censored, outcomes.
Biometrics
; 72(3): 926-35, 2016 09.
Article
in English
| MEDLINE | ID: mdl-26812695
10.
Assessing survival benefit when treatment delays disease progression.
Clin Trials
; 13(3): 352-7, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26908538
11.
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
Breast Cancer Res
; 17: 56, 2015 Apr 16.
Article
in English
| MEDLINE | ID: mdl-25888246
12.
A model-informed rank test for right-censored data with intermediate states.
Stat Med
; 34(9): 1454-66, 2015 Apr 30.
Article
in English
| MEDLINE | ID: mdl-25582933
13.
Breast cancer in China.
Lancet Oncol
; 15(7): e279-89, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24872111
14.
Long-term risk of medical conditions associated with breast cancer treatment.
Breast Cancer Res Treat
; 145(1): 233-43, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24696430
15.
Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective.
BMC Cancer
; 14: 658, 2014 Sep 09.
Article
in English
| MEDLINE | ID: mdl-25199766
16.
A joint test for progression and survival with interval-censored data from a cancer clinical trial.
Stat Med
; 33(12): 1981-9, 2014 May 30.
Article
in English
| MEDLINE | ID: mdl-24500790
17.
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.
Lancet Oncol
; 14(1): 88-96, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23234763
18.
Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?
Breast Cancer Res Treat
; 140(3): 485-94, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23912961
19.
Breast cancer in Brazil: present status and future goals.
Lancet Oncol
; 13(3): e95-e102, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22381937
20.
Breast cancer in Mexico: a growing challenge to health and the health system.
Lancet Oncol
; 13(8): e335-43, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22846838